Tumor necrosis factor inhibitors for rheumatoid arthritis.
Okamoto
Hiroshi
H
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology; D000917:Antibody Formation; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007108:Immune Tolerance; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab